Valeo Financial Advisors’s 10x Genomics TXG Stock Holding History

Valeo Financial Advisors’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-107	Closed	-$19K	–	1727
2021 Q1	$19K	Sell	107 -4	-4%	-$691	﹤0.01%	1187
2020 Q4	$16K	Buy	111 +22	+25%	+$3.19K	﹤0.01%	1094
2020 Q3	$11K	Sell	89 -400	-82%	-$42K	﹤0.01%	1070
2020 Q2	$44K	Buy	489 +239	+96%	+$18.6K	﹤0.01%	781
2020 Q1	$16K	Hold	250	–	–	﹤0.01%	949
2019 Q4	$19K	Hold	250	–	–	﹤0.01%	938
2019 Q3	$13K	Buy	+250	New	+$13.8K	﹤0.01%	968

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

MCAV

Meritech Capital Associates V Palo Alto, California $141M AUM 15.44% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Valeo Financial Advisors's TXG Position: Q2 2021 in Review

Valeo Financial Advisors sold out of 10x Genomics (TXG) in Q2 2021, closing a stake of 107 shares — an estimated $19K sold.

Valeo Financial Advisors first reported a position in TXG in Q3 2019 and held it in 7 quarters. The position peaked at $44K in Q2 2020. 340 funds tracked by Wall St. Rank hold TXG as of Q2 2021.

Valeo Financial Advisors reported no remaining 10x Genomics position as of Q2 2021 after selling out during the quarter.
Valeo Financial Advisors sold 107 10x Genomics shares in Q2 2021, an estimated $19K.
Valeo Financial Advisors first reported a position in 10x Genomics in Q3 2019 and held it in 7 quarters.
Valeo Financial Advisors's 10x Genomics position peaked at $44K in Q2 2020.
340 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2021.

Based on Valeo Financial Advisors's 13F filing for Q2 2021, filed 22 Jul 2021.